Targeting APOC3 in the Familial Chylomicronemia Syndrome
Targeting APOC3 in the Familial Chylomicronemia Syndrome
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this study, investigators found that APOC3, a key regulator of triglyceride metabolism, had a profound and clinically relevant effect on triglyceride levels through a mechanism that is independent of lipoprotein lipase.
The familial chylomicronemia syndrome is a rare autosomal recessive disease characterized by the buildup in the blood of fat...
Alternative Titles
Full title
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1634281050
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1634281050
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1400284
